Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HIVE Stock Summary
Top 10 Correlated ETFs
HIVE
In the News
HIVE Financial details
Company Rating
Sell
Market Cap
298.1M
Income
-61.86M
Revenue
98.37M
Book val./share
2.04
Cash/share
0.28
Dividend
-
Dividend %
-
Employees
18
Optionable
No
Shortable
Yes
Earnings
28 Jun 2024
P/E
-2.46
Forward P/E
-
PEG
0.14
P/S
4.87
P/B
2.91
P/C
9.3
P/FCF
-38.54
Quick Ratio
0.67
Current Ratio
2.52
Debt / Equity
0.18
LT Debt / Equity
0.11
-
-
EPS (TTM)
-0.73
EPS next Y
-
EPS next Q
-
EPS this Y
-376.7%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.41%
Revenue last 5Y
45.4%
Revenue Q/Q
84.51%
EPS Q/Q
-72.83%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0.04%
Inst Trans
0%
ROA
-85%
ROE
-105%
ROC
-0.49%
Gross Margin
-64%
Oper. Margin
-93%
Profit Margin
-192%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.75-6.84
52W High
-56.58%
52W Low
+30.25%
RSI
30
Rel Volume
0.61
Avg Volume
2.85M
Volume
1.73M
Perf Week
-14.31%
Perf Month
-23.16%
Perf Quarter
-15.42%
Perf Half Y
-17.04%
-
-
-
-
Beta
4.288
-
-
Volatility
0.14%, 0.22%
Prev Close
0.19%
Price
2.605
Change
-3.52%
HIVE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.26 | 0.45 | 1.45 | 2.72 | 1.28 | |
Net income per share | -2.19 | -0.03 | 0.61 | 1.02 | -2.85 | |
Operating cash flow per share | -0.03 | 0.01 | 0.33 | 0.88 | 0.54 | |
Free cash flow per share | -0.06 | -0.02 | -0.61 | -1.89 | 0.02 | |
Cash per share | 0.14 | 0.13 | 0.59 | 0.29 | 0.09 | |
Book value per share | 0.35 | 0.32 | 1.94 | 5.01 | 1.8 | |
Tangible book value per share | 0.3 | 0.32 | 1.93 | 5 | 1.79 | |
Share holders equity per share | 0.35 | 0.32 | 1.94 | 5.01 | 1.8 | |
Interest debt per share | 0.03 | 0.08 | 0.46 | 0.61 | 0.47 | |
Market cap | 125.83M | 45.77M | 1.35B | 827.67M | 272.65M | |
Enterprise value | 121.85M | 45.69M | 1.34B | 865.67M | 303.69M | |
P/E ratio | -0.91 | -27.52 | 31.82 | 10.4 | -1.15 | |
Price to sales ratio | 7.69 | 1.56 | 13.48 | 3.92 | 2.56 | |
POCF ratio | -76.64 | 59.47 | 58.98 | 12.09 | 6.09 | |
PFCF ratio | -30.8 | -41.23 | -32.01 | -5.65 | 139.67 | |
P/B Ratio | 5.73 | 2.17 | 10.07 | 2.13 | 1.83 | |
PTB ratio | 5.73 | 2.17 | 10.07 | 2.13 | 1.83 | |
EV to sales | 7.45 | 1.55 | 13.39 | 4.1 | 2.86 | |
Enterprise value over EBITDA | 1.52 | 13.96 | 17.51 | 5.92 | -6.92 | |
EV to operating cash flow | -74.21 | 59.38 | 58.57 | 12.64 | 6.78 | |
EV to free cash flow | -29.82 | -41.16 | -31.78 | -5.91 | 155.57 | |
Earnings yield | -1.1 | -0.04 | 0.03 | 0.1 | -0.87 | |
Free cash flow yield | -0.03 | -0.02 | -0.03 | -0.18 | 0.01 | |
Debt to equity | 0.13 | 0.24 | 0.23 | 0.11 | 0.24 | |
Debt to assets | 0.1 | 0.17 | 0.17 | 0.1 | 0.18 | |
Net debt to EBITDA | -0.05 | -0.02 | -0.12 | 0.26 | -0.71 | |
Current ratio | 2.69 | 2.53 | 10.91 | 7.66 | 3.77 | |
Interest coverage | 58.33 | -7.23 | 54.45 | 20.49 | -33.89 | |
Income quality | 0.01 | -0.46 | 0.54 | 0.86 | -0.19 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.24 | 0.16 | 0.06 | 0.08 | 0.18 | |
Research and developement to revenue | 2.18 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.08 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 1.49 | -2.44 | -2.84 | -3.14 | -0.96 | |
Capex to revenue | -0.15 | -0.06 | -0.65 | -1.02 | -0.4 | |
Capex to depreciation | -0.08 | -0.3 | -6.11 | -3.21 | -0.52 | |
Stock based compensation to revenue | 0.07 | 0.02 | 0.02 | 0.03 | 0.08 | |
Graham number | 4.15 | 0.43 | 5.17 | 10.74 | 10.74 | |
ROIC | -1.76 | -0.21 | 0.39 | 0.17 | -0.65 | |
Return on tangible assets | -5.41 | -0.06 | 0.24 | 0.18 | -1.21 | |
Graham Net | 0.11 | 0.14 | 0.45 | 0.64 | 0 | |
Working capital | 9.84M | 11.09M | 97.68M | 174.14M | 60.6M | |
Tangible asset value | 19.64M | 21.09M | 133.87M | 388.72M | 148.75M | |
Net current asset value | 9.84M | 10.32M | 63.68M | 137.08M | 35.19M | |
Invested capital | 0.13 | 0.24 | 0.23 | 0.11 | 0.24 | |
Average receivables | 13.88M | 5.77M | 7.97M | 7.41M | 8.67M | |
Average payables | 14.04M | 9.13M | 2.8M | 7.93M | 9.62M | |
Average inventory | 5.96M | 3.81M | 30.48M | 113.75M | 117.95M | |
Days sales outstanding | 54.4 | 113.01 | 24.88 | 13.78 | 32.11 | |
Days payables outstanding | 106.36 | 28 | 45.16 | 39.1 | 18.01 | |
Days of inventory on hand | 27.42 | 45.42 | 746.61 | 537.08 | 173.06 | |
Receivables turnover | 6.71 | 3.23 | 14.67 | 26.48 | 11.37 | |
Payables turnover | 3.43 | 13.04 | 8.08 | 9.33 | 20.26 | |
Inventory turnover | 13.31 | 8.04 | 0.49 | 0.68 | 2.11 | |
ROE | -6.28 | -0.08 | 0.32 | 0.2 | -1.59 | |
Capex per share | -0.04 | -0.03 | -0.94 | -2.77 | -0.52 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.17 | 0.22 | 0.27 | 0.24 | 0.42 | |
Net income per share | -1.09 | -0.17 | -0.19 | -0.29 | -0.08 | |
Operating cash flow per share | 0.16 | -0.02 | 0.19 | 0.06 | 0.13 | |
Free cash flow per share | -0.01 | -0.05 | 0 | -0.06 | -0.3 | |
Cash per share | 0.17 | 0.09 | 0.08 | 0.08 | 0.28 | |
Book value per share | 1.7 | 1.77 | 1.68 | 1.45 | 2.04 | |
Tangible book value per share | 1.7 | 1.77 | 1.68 | 1.45 | 2.04 | |
Share holders equity per share | 1.7 | 1.77 | 1.68 | 1.45 | 2.04 | |
Interest debt per share | 0.46 | 0.43 | 0.41 | 0.39 | 0.38 | |
Market cap | 119.09M | 276.93M | 390.05M | 261.96M | 399.79M | |
Enterprise value | 147.46M | 307.97M | 419.4M | 289.8M | 414.84M | |
P/E ratio | -0.33 | -4.91 | -6 | -2.67 | -14.38 | |
Price to sales ratio | 8.32 | 15.2 | 16.97 | 13.04 | 10.78 | |
POCF ratio | 8.84 | -134.38 | 24.14 | 49.55 | 33.73 | |
PFCF ratio | -164.3 | -66.95 | 2.54K | -54.1 | -15.32 | |
P/B Ratio | 0.85 | 1.86 | 2.75 | 2.13 | 2.22 | |
PTB ratio | 0.85 | 1.86 | 2.75 | 2.13 | 2.22 | |
EV to sales | 10.3 | 16.9 | 18.24 | 14.42 | 11.19 | |
Enterprise value over EBITDA | -18.56 | 59.32 | 164.15 | -51.19 | 49.9 | |
EV to operating cash flow | 10.95 | -149.44 | 25.95 | 54.81 | 35 | |
EV to free cash flow | -203.44 | -74.45 | 2.73K | -59.85 | -15.9 | |
Earnings yield | -0.76 | -0.05 | -0.04 | -0.09 | -0.02 | |
Free cash flow yield | -0.01 | -0.01 | 0 | -0.02 | -0.07 | |
Debt to equity | 0.26 | 0.24 | 0.24 | 0.26 | 0.18 | |
Debt to assets | 0.2 | 0.18 | 0.18 | 0.19 | 0.14 | |
Net debt to EBITDA | -3.57 | 5.98 | 11.49 | -4.92 | 1.81 | |
Current ratio | 2.86 | 3.77 | 3.12 | 2.52 | 3.51 | |
Interest coverage | -28.17 | -7.92 | -15.84 | -26.53 | -9.62 | |
Income quality | -0.15 | 0.15 | -0.99 | -0.22 | -1.71 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.41 | 0.31 | 0.16 | 0.38 | 0.08 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.05 | 1.01 | -0.99 | -1.92 | -3.2 | |
Capex to revenue | -0.99 | -0.11 | -0.7 | -0.5 | -1.02 | |
Capex to depreciation | -0.7 | -0.18 | -0.97 | -0.61 | -2.31 | |
Stock based compensation to revenue | 0.18 | 0.16 | 0.09 | 0.2 | 0.02 | |
Graham number | 6.46 | 2.58 | 2.7 | 3.06 | 1.9 | |
ROIC | -0.15 | -0.03 | -0.08 | -0.14 | -0.05 | |
Return on tangible assets | -0.48 | -0.07 | -0.09 | -0.14 | -0.03 | |
Graham Net | -0.08 | 0 | -0.04 | -0.11 | 0.18 | |
Working capital | 41.54M | 60.6M | 51.15M | 38.55M | 74.96M | |
Tangible asset value | 140.74M | 148.75M | 141.58M | 122.9M | 180.05M | |
Net current asset value | 15.34M | 35.19M | 28.48M | 16.9M | 53.63M | |
Invested capital | 0.26 | 0.24 | 0.24 | 0.26 | 0.18 | |
Average receivables | 8.11M | 10.06M | 9.16M | 9.5M | 9.11M | |
Average payables | 9.97M | 8.22M | 6.7M | 6.7M | 7.5M | |
Average inventory | 51.94M | 52.43M | 62.72M | 53.22M | 59.39M | |
Days sales outstanding | 67.62 | 46.2 | 35.1 | 44.92 | 19.89 | |
Days payables outstanding | 27.78 | 23.85 | 18.01 | 17.75 | 19.68 | |
Days of inventory on hand | 112.93 | 229.16 | 163.82 | 121.61 | 173.48 | |
Receivables turnover | 1.33 | 1.95 | 2.56 | 2 | 4.52 | |
Payables turnover | 3.24 | 3.77 | 5 | 5.07 | 4.57 | |
Inventory turnover | 0.8 | 0.39 | 0.55 | 0.74 | 0.52 | |
ROE | -0.64 | -0.09 | -0.11 | -0.2 | -0.04 | |
Capex per share | -0.17 | -0.02 | -0.19 | -0.12 | -0.43 |
HIVE Frequently Asked Questions
What is HIVE Blockchain Technologies Ltd. stock symbol ?
HIVE Blockchain Technologies Ltd. is a CA stock , located in Vancouver of Bc and trading under the symbol HIVE
What is HIVE Blockchain Technologies Ltd. stock quote today ?
HIVE Blockchain Technologies Ltd. stock price is $2.605 today.
Is HIVE Blockchain Technologies Ltd. stock public?
Yes, HIVE Blockchain Technologies Ltd. is a publicly traded company.